ADVERTISEMENT
News
Antidiuretic Tablets Recalled
02/28/2020
The recall affects the following products, which were packaged and distributed by American Health Packaging throughout the United States:
- desmopressin acetate tablets, 0.1 mg, 30 tablets (3x10 unit dose blister cards; carton NDC 68084-606-21, unit dose NDC 68084-606-11) from lot 181109 (Exp. 4/30/20); and
- desmopressin acetate tablets, 0.2 mg, 30 tablets (3x10 unit dose blister cards; carton NDC 68084-604-21, unit dose NDC 68084-604-11) from lots 180510 (Exp. 3/31/20) and 181912 (Exp. 4/30/20).
American Health Packaging voluntarily initiated the recall February 7, 2020. On February 18, 2020, the FDA designated the recall Class II. Use of a product under a Class II recall could cause temporary or medically reversible adverse health consequences, or a remote possibility of serious harm.
Desmopressin is a prescription clotting promotor and antidiuretic used to treat patients with diabetes insipidus, bedwetting problems, and bleeding disorders.
—Jolynn Tumolo